BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 26293329)

  • 1. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates.
    Allen MR
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):497-508. PubMed ID: 26277349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
    Fusco V; Santini D; Armento G; Tonini G; Campisi G
    Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-associated osteonecrosis of the jaw.
    Khan A
    Can Fam Physician; 2008 Jul; 54(7):1019-21. PubMed ID: 18625828
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
    Aragon-Ching JB; Dahut WL
    Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
    [No Abstract]   [Full Text] [Related]  

  • 10. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.
    McMahon RE; Bouquot JE; Glueck CJ; Griep JA; Adams WR; Spolnik KJ; Deardorf KA
    J Oral Maxillofac Surg; 2007 Sep; 65(9):1899-900. PubMed ID: 17719423
    [No Abstract]   [Full Text] [Related]  

  • 11. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?
    Yarom N; Fedele S; Lazarovici TS; Elad S
    J Oral Maxillofac Surg; 2010 Mar; 68(3):705. PubMed ID: 20171493
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw.
    Fantasia JE
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):547-53. PubMed ID: 26515736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
    Colella G; Campisi G; Fusco V
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
    [No Abstract]   [Full Text] [Related]  

  • 17. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
    Ruggiero SL; Dodson TB; Fantasia J; Goodday R; Aghaloo T; Mehrotra B; O'Ryan F;
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1938-56. PubMed ID: 25234529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].
    Dannemann C; Grätz KW; Zwahlen RA
    Schweiz Monatsschr Zahnmed; 2008; 118(2):113-23. PubMed ID: 18361180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
    Carlson ER
    Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.